Multimodal biomicroscopic system enhances the accuracy of cancer treatment

January 9, 2018, Daegu Gyeongbuk Institute of Science and Technology
Conceptual diagram showing characteristics of Multimodal Biomicroscopic System. Credit: Daegu Gyeongbuk Institute of Science and Technology (DGIST)

A research team of Information and Communication Engineering at DGIST has developed the world's first multimodal biomicroscopic system to analyze the characteristics of tumors and to utilize them in tumor treatment technology research. The new imaging system accurately analyzes the characteristics of tumors using the mechanical, chemical, and structural properties of colorectal cancer. It is the result of a collaboration with the research team of Eunjoo Kim from the Department of Nano & Energy Research.

Histopathologic examination of tumors removed during surgery is important. In particular, if a small part of the tumor is left in the patient, it becomes the cause of cancer recurrence or metastasis. Therefore, it is necessary to accurately analyze the removed tumor to find out whether cancer remains in the surgical site.

For analysis, it is necessary to send a resected tumor to a pathologist to examine the specimen with a microscope to determine whether the resected cancer tissue is appropriately acquired and whether additional resection of the tissue during surgery is necessary. However, this process is time consuming, and the results may vary depending on internal and external factors. To overcome these disadvantages, optical microscopy or ultrasonic wave technology are used. However, it is difficult to perform close inspection, as these methods have low resolution and cannot analyze the tissue internally.

Professor Hwang's research team has developed a converged biomicroscope based on high-frequency ultrasound and optical spectroscopy to overcome the disadvantages of the imaging systems previously developed for tumor analysis. The multimodal biomicroscopic system is capable of performing pathologic analysis simultaneously to detect the surface of resected tissues and tumors deep within the tissues during the cancer operation. It converges optical multispectral imaging, high-frequency ultrasound B-mode, and high-frequency ultrasound radiation imaging techniques.

Tissue and tumor areas can be analyzed more precisely than via a general fluorescence microscope as the optical spectroscopic imaging technique quantitatively analyzes the spectroscopic indicators emitted from the tissue surface. It is possible to detect deep tissue as well as tumor areas accurately with high frequency ultrasonic b-mode and high frequency ultrasonic radiation force imaging technique, as they image the impedance and elasticity inside the tissue at higher resolution than the existing ultrasonic imaging techniques.

Through the experiment, the research team has proved that multimodal biomicroscopic system enables mechanical, chemical, and structural analysis of the tumor from colon cancer patients at the high resolution from the surface to the deep of the tumor.

Professor Hwang said, "We have developed a multimodal biomicroscopic system based on high-frequency ultrasound and optical spectroscopy for the first time. It complements the disadvantages of the existing image analysis systems. We will conduct further studies to develop this system to the endoscope system which can be used for clinical diagnosis of cancer before the actual surgery."

The results of this study show that the multimodal biomicroscopic system has the potential to qualitatively investigate the characteristics of incised tumors in vitro. The multimodal biomicroscopic system is expected to improve the efficiency and success rate of surgery by increasing the accuracy of removal surgery as well as shortening the operation time.

Explore further: Multifunctional fluorescent nanoparticles for cancer surgery show promise

More information: Jihun Kim et al, A Multimodal Biomicroscopic System based on High-frequency Acoustic Radiation Force Impulse and Multispectral Imaging Techniques for Tumor Characterization Ex vivo, Scientific Reports (2017). DOI: 10.1038/s41598-017-17367-1

Related Stories

Multifunctional fluorescent nanoparticles for cancer surgery show promise

November 14, 2017
Even with pre-operative imaging techniques, surgeons still rely on visual inspection to locate malignant tissues during surgery. New research released today at the 2017 American Association of Pharmaceutical Scientists (AAPS) ...

Precise 3-D imaging of skin cancer tumours

November 15, 2017
Scientists and clinicians from Singapore and Germany have successfully used multispectral optoacoustic tomography (MSOT) to achieve accurate, real-time 3-D imaging of non-melanoma skin cancer tumours. This imaging technique ...

Recommended for you

More clues revealed in link between normal breast changes and invasive breast cancer

October 15, 2018
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process—changes in mammary glands to accommodate breastfeeding—uses a molecular process believed ...

Cancer stem cells use 'normal' genes in abnormal ways

October 12, 2018
CDK1 is a "normal" protein—its presence drives cells through the cycle of replication. And MHC Class I molecules are "normal" as well—they present bits of proteins on the surfaces of cells for examination by the immune ...

Obesity linked to increased risk of early-onset colorectal cancer

October 12, 2018
Women who are overweight or obese have up to twice the risk of developing colorectal cancer before age 50 as women who have what is considered a normal body mass index (BMI), according to new research led by Washington University ...

Potential therapy for treatment-resistant hypothyroidism proves effective in lab study

October 12, 2018
A new "metal-coordinated" drug-delivery technology potentially could be used to supplement the standard therapy for hypothyroidism, which affects nearly 10 million Americans, and many more patients worldwide, according to ...

Researchers find a 'critical need' for whole genome sequencing of young cancer patients

October 12, 2018
St. Jude Children's Research Hospital has re-defined the gold standard for diagnostic testing of childhood cancer patients in the precision-medicine era and has implemented the testing for new cancer patients. The findings ...

Immune cells in triple-negative breast cancer offer potential therapeutic target

October 11, 2018
About 15 percent of breast cancers are classified as triple-negative, lacking receptors for estrogen, progesterone, and Her2. These cancers do not respond to targeted hormonal therapies, and they tend to be particularly aggressive, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.